These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4038693)

  • 1. Use of nifedipine in hypertrophic cardiomyopathy in infants. A report of two cases.
    Dickinson DF; Wilson N; Curry P
    Int J Cardiol; 1985 Feb; 7(2):159-60. PubMed ID: 4038693
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute effects of nifedipine in hypertrophic cardiomyopathy. Echocardiographic and hemodynamic study].
    Terrosu P; Dore L; Sannia L; Piras L; Ibba GV
    Boll Soc Ital Cardiol; 1981; 26(12):1973-7. PubMed ID: 6892233
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nifedipine in the treatment of hypertrophic non-obstructive cardiomyopathy].
    Senn M; Hess OM; Krayenbühl HP
    Schweiz Med Wochenschr; 1982 Sep; 112(38):1312-7. PubMed ID: 6215710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of hypertrophic cardiomyopathy with nifedipine and propranolol in combination].
    Hopf R; Thomas J; Klepzig H; Kaltenbach M
    Z Kardiol; 1987 Aug; 76(8):469-78. PubMed ID: 3673167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nifedipine and propranolol combined therapy in patients with hypertrophic cardiomyopathy.
    Hopf R; Kaltenbach M
    Z Kardiol; 1987; 76 Suppl 3():105-12. PubMed ID: 3433863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nifedipine in hypertrophic cardiomyopathy.
    Pouleur H; Rousseau MF
    Circulation; 1982 Aug; 66(2):478-9. PubMed ID: 7201360
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the effects of nitroprusside and nifedipine on diastolic properties in patients with hypertrophic cardiomyopathy: altered left ventricular loading or improved muscle inactivation?
    Paulus WJ; Lorell BH; Craig WE; Wynne J; Murgo JP; Grossman W
    J Am Coll Cardiol; 1983 Nov; 2(5):879-86. PubMed ID: 6685150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy.
    Lorell BH; Paulus WJ; Grossman W; Wynne J; Cohn PF
    Circulation; 1982 Mar; 65(3):499-507. PubMed ID: 7198942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved diastolic function and systolic performance in hypertrophic cardiomyopathy after nifedipine.
    Lorell BH; Paulus WJ; Grossman W; Wynne J; Cohn PF; Braunwald E
    N Engl J Med; 1980 Oct; 303(14):801-3. PubMed ID: 7191052
    [No Abstract]   [Full Text] [Related]  

  • 10. [Calcium antagonists in hypertrophic cardiomyopathy].
    Nartowicz E; Ukleja-Adamowicz M
    Pol Tyg Lek; 1988 Oct; 43(44):1395-8. PubMed ID: 3252203
    [No Abstract]   [Full Text] [Related]  

  • 11. [Stress pulsed Doppler echocardiography in the evaluation of diastolic left ventricular function].
    Asai M; Oki T; Ohkushi H; Ishimoto T; Tominaga T; Taoka M; Fukuda N; Niki T; Mori H
    J Cardiogr; 1985 Jun; 15(2):399-413. PubMed ID: 2936836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nifedipine in hypertrophic obstructive cardiomyopathy].
    Schanzenbächer P; Schick KD; Kochsiek K
    Dtsch Med Wochenschr; 1982 Dec; 107(48):1842-6. PubMed ID: 6890438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of calcium channel blockers in hypertrophic cardiomyopathy.
    Lorell BH
    Am J Med; 1985 Feb; 78(2B):43-54. PubMed ID: 4038850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term therapy of hypertrophic obstructive and non-obstructive cardiomyopathy with nifedipine in comparison to propranolol].
    Cserhalmi L; Assmann I; Glavanov M; Rev J; Kelecseńeyi Z
    Z Gesamte Inn Med; 1984 Jul; 39(14):330-5. PubMed ID: 6435321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute action of nifedipine in patients with obstructive and nonobstructive asymmetrical septum hypertrophy (ASH)].
    Békés M; Cserhalmi L; Glavanov M; Csukás A; Szilágyi M; Huszár G
    Med Welt; 1980 Sep; 31(39):1408-11. PubMed ID: 6450306
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy.
    Landmark K; Sire S; Thaulow E; Amlie JP; Nitter-Hauge S
    Br Heart J; 1982 Jul; 48(1):19-26. PubMed ID: 7200796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between serum nifedipine concentration and hemodynamic effects in nonobstructive hypertrophic cardiomyopathy.
    Betocchi S; Bonow RO; Cannon RO; Lesko LJ; Ostrow HG; Watson RM; Rosing DR
    Am J Cardiol; 1988 Apr; 61(10):830-5. PubMed ID: 3354448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sublingual nifedipine on hemodynamics and systolic and diastolic function in patients with hypertrophic cardiomyopathy.
    Betocchi S; Cannon RO; Watson RM; Bonow RO; Ostrow HG; Epstein SE; Rosing DR
    Circulation; 1985 Nov; 72(5):1001-7. PubMed ID: 4042288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of cardiomyopathy using Ca blockers].
    Matsumori A; Tominaga M; Kawai C
    Nihon Rinsho; 1989 Aug; 47(8):1825-30. PubMed ID: 2585747
    [No Abstract]   [Full Text] [Related]  

  • 20. Adverse effects of nifedipine therapy on hypertrophic obstructive cardiomyopathy.
    Fedor JM; Stack RS; Pryor DB; Phillips HR
    Chest; 1983 Apr; 83(4):704-6. PubMed ID: 6682029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.